| ||
| Mild winter, spring's arrival herald allergies NECN Left untreated, they can lead to chronic sinus infections, ear infections, asthma and fatigue. "The good news is, we have outstanding treatments," Nsouli said. Treatments include medications, allergy shots and avoiding the allergens. See all stories on this topic » | ||
| ||
| ||
| Early pollen means more, longer suffering for allergy victims Anderson Independent Mail For those with allergies, the pollen signals not a return to warmer weather and leafy green trees, but a drive to the pharmacy for allergy medications. Lisa Senn said her son Gil, age 12, suffers from allergy-induced asthma during pollen season. See all stories on this topic » | ||
| Boston Scientific Welcomes Positive Private Insurance Coverage Decisions for ... MarketWatch (press release) The results of the AIR2 Trial, published in the January 15, 2010 issue of the American Journal of Respiratory and Critical Care Medicine (AJRCCM) found that in the year following BT, severe asthma patients treated with the Alair System experienced the ... See all stories on this topic » | ||
| Reimbursement Decision for BSX' Alair Zacks.com The Alair BT system provides long lasting and improved asthma control for adult patients suffering from severe asthma who have not benefited from currently approved inhaled medications. Alair was inducted in Boston Scientific's portfolio with its ... See all stories on this topic » | ||
| Asthma Medication Adherence Is Poor Global Medical News Network Overall adherence to asthma controller medication was poor, but men were more adherent than women for most medications in an analysis of claims from a large database. Dr. Leslie J. Hinyard, Ph.D., discusses the results. See all stories on this topic » | ||
| ||
| Novartis launches Arcapta(TM) Neohaler(TM), a novel once-daily bronchodilator ... MarketWatch (press release) Arcapta Neohaler is not indicated to treat asthma. It is also not indicated to treat acute deteriorations of COPD and should not be used as a rescue medication for acute symptoms. Arcapta Neohaler is the only once-daily, 24-hour long-acting ... See all stories on this topic » |
Tuesday, March 20, 2012
Asthma medications
Labels:
asthma medication
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment